Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Read runs and technical replicates

    So I've downloaded some example data from SRA archives at http://www.ncbi.nlm.nih.gov/sra?term=SRA011001 and had a question about technical and biological replicates (see attached picture for a snapshot of the downloads). I know that there are two biological replicates for control and treatment conditions (in this case a miR155 over-expression retrovirus) but I'm not sure about the technical replicates.

    Do read runs count as technical replicates?

    And, if so, how can I use that in my analysis pipeline (currently I'm using the Tuxedo suite (i.e. tophat > cufflinks > cuffmerge, etc.)).

    Right now I think I'm just telling the program that there are six biological replicates of each condition (i.e. 6 x miR155oe vs. 6 x control) which is probably wrong.

    Thanks, Scott
    Attached Files

  • #2
    It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.

    Comment


    • #3
      Originally posted by chadn737 View Post
      It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.
      Is there paper where this is shown?

      So perhaps I should merge my .sam files per biological replicate and then do the tophat/bowtie alignment?

      Thanks.

      Comment


      • #4
        Marioni, J. C., C. E. Mason, S. M. Mane, M. Stephens and Y. Gilad,
        2008 RNA-Seq: an assessment of technical reproducibility and
        comparison with gene expression arrays. Genome Res. 18: 1509–1517.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          New Genomics Tools and Methods Shared at AGBT 2025
          by seqadmin


          This year’s Advances in Genome Biology and Technology (AGBT) General Meeting commemorated the 25th anniversary of the event at its original venue on Marco Island, Florida. While this year’s event didn’t include high-profile musical performances, the industry announcements and cutting-edge research still drew the attention of leading scientists.

          The Headliner
          The biggest announcement was Roche stepping back into the sequencing platform market. In the years since...
          03-03-2025, 01:39 PM
        • seqadmin
          Investigating the Gut Microbiome Through Diet and Spatial Biology
          by seqadmin




          The human gut contains trillions of microorganisms that impact digestion, immune functions, and overall health1. Despite major breakthroughs, we’re only beginning to understand the full extent of the microbiome’s influence on health and disease. Advances in next-generation sequencing and spatial biology have opened new windows into this complex environment, yet many questions remain. This article highlights two recent studies exploring how diet influences microbial...
          02-24-2025, 06:31 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, Today, 12:50 PM
        0 responses
        6 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 03-03-2025, 01:15 PM
        0 responses
        181 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 02-28-2025, 12:58 PM
        0 responses
        275 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 02-24-2025, 02:48 PM
        0 responses
        663 views
        0 likes
        Last Post seqadmin  
        Working...
        X